Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor update to the study page.
    Difference
    0.0%
    Check dated 2026-06-05T10:18:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new page revision tag: 'Revision: v3.5.4', and removed the previous tag 'Revision: v3.5.3'.
    Difference
    0.0%
    Check dated 2026-05-15T05:55:59.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label has been incremented from v3.5.2 to v3.5.3, reflecting a release/version update rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:48.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:13.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T01:15:39.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3; the v3.4.2 tag was removed.
    Difference
    0.0%
    Check dated 2026-03-11T19:57:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.